UNSPSC 51151645: Isopropamide

This classification denotes an anticholinergic agent with the molecular formula C23H33N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8B9I31H724, chemically known as 4-(diisopropylamino)-2,2-diphenylbutyramide methiodide but generally known as isopropamide, which bears US NIH Compound Identifier 3775. European Medicines Agency schedules Isopropamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02799MIG.

UNSPSC 51151645 Isopropamide is a Commodity code that in recent state and local procurement activity covers pharmaceutical products and related health system supplies, though the recent opportunities posted under this code show minimal direct alignment with isopropamide itself. Seminole County, Florida issued IFB60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building and a two-year initial term plus one-year renewal option. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather market intelligence on direct-to-manufacturer prescription fulfillment capabilities, seeking vendor experience with self-insured employer contracting, negotiated net pricing models, and outcomes-based agreements to inform future pharmacy benefit program procurement strategy. Issuing bodies under this code include county health departments and state health and human services agencies; recent activity shows health-focused government entities sourcing pharmaceutical supplies and pharmacy benefit services through both traditional competitive bidding and exploratory information-gathering mechanisms.

Geographic activity in the recent opportunities centers on Florida and Texas, with Seminole County Community Health Building serving as the performance location for the naloxone and deactivation-systems procurement and the Texas HHS Commission conducting statewide pharmacy benefit program research. The Seminole County opportunity (IFB60459723LAS, due July 26, 2023) requires electronic bid submission through the county's e-Procurement Portal, includes quarterly delivery requirements, and mandates drug-free workplace certification and E-Verify compliance; the contract features a three-month probationary termination period and potential FEMA funding with associated federal environmental compliance obligations. The Texas RFI (HHS0017013, posted April 3, 2026) functions as a preliminary market-intelligence vehicle rather than a formal competitive solicitation and does not specify budget, set-asides, or award timelines; it signals the state's intent to develop formal procurement specifications for pharmacy benefit programs following the information-gathering phase.